Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axonics Inc
(NQ:
AXNX
)
70.98
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axonics Inc
< Previous
1
2
3
4
5
6
7
Next >
AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders
January 08, 2024
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 08, 2024
Via
Benzinga
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Peeling Back The Layers: Exploring Axonics Through Analyst Insights
December 22, 2023
Via
Benzinga
Earnings Outlook For Axonics
October 27, 2023
Via
Benzinga
Analyst Ratings for Axonics
July 28, 2023
Via
Benzinga
Axonics to Present at the J.P. Morgan Healthcare Conference
December 27, 2023
From
Axonics, Inc.
Via
Business Wire
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
November 06, 2023
From
NeuroQure
Via
GlobeNewswire
Axonics to Participate in November Investor Conferences
November 01, 2023
From
Axonics, Inc.
Via
Business Wire
Why Shares of Axonics Rose Friday
July 28, 2023
The company showed improved revenue and margins in its second-quarter report.
Via
The Motley Fool
Earnings Outlook For Axonics
July 26, 2023
Via
Benzinga
The Latest Analyst Ratings for Axonics
July 12, 2023
Via
Benzinga
Where Axonics Stands With Analysts
May 23, 2023
Via
Benzinga
Axonics Reports Third Quarter 2023 Financial Results
October 30, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Report Third Quarter 2023 Financial Results on October 30
October 02, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Participate in September Investor Conferences
August 25, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Announces CFO Retirement and Appoints Successor
August 21, 2023
From
Axonics, Inc.
Via
Business Wire
Analyst Ratings for Axonics
May 02, 2023
Via
Benzinga
Earnings Scheduled For October 30, 2023
October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
Via
Benzinga
Axonics Reports Second Quarter 2023 Financial Results
July 27, 2023
From
Axonics, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
July 24, 2023
Via
Benzinga
Axonics Positioned For Rapid Penetration In Underserved Market, Analyst Initiates With Bullish Tone
July 13, 2023
KeyBanc Capital markets initiated coverage on Axonics Inc (NASDAQ: AXNX) with an Overweight rating and a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
July 13, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
July 19, 2023
Via
Benzinga
Axonics to Report Second Quarter 2023 Financial Results on July 27
June 29, 2023
From
Axonics, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
May 23, 2023
Via
Benzinga
Axonics Q1 Soars Past Estimates: Analysts Say Annual Sales Outlook Is 'Conservative'
May 02, 2023
Axonics Inc (NASDAQ: AXNX) reported a Q1 EPS loss of $(0.19), better than the consensus of $(0.29).
Via
Benzinga
Axonics Reports First Quarter 2023 Financial Results
May 01, 2023
From
Axonics, Inc.
Via
Business Wire
Earnings Scheduled For May 1, 2023
May 01, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.